Australian Clinical Labs Limited
ACL
Rank in Stocks
#13038
Australian Clinical Labs Limited operates across Australia, delivering a... Australian Clinical Labs Limited operates across Australia, delivering a diverse range of diagnostic pathology services. The company's extensive portfolio encompasses standard examinations alongside advanced molecular genetics, including Harmony NIPT and initial trimester screenings, as well as genetic carrier screening. Furthermore, it provides detailed analyses in chemical, tissue (histopathology), and cellular (cytopathology) pathology; specialized tests for hematology, allergies, and immunology; and comprehensive serology and microbiology services. ACL also performs infectious molecular testing, cardiac diagnostic assessments, functional pathology, veterinary pathology, and commercial drug and alcohol screening. These essential services are supplied to both private and public hospitals throughout the nation. The company was founded in 2020 and maintains its primary operational base in Clayton, Australia.
Share Price
$2.25
Last synced: 2026-11-10
Market Cap
$419.60M
Change (1 day)
-0.91%
Change (1 year)
27.44%
Country
Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this
Trade Australian Clinical Labs Limited (ACL)
Category
Healthcare
Operating Margin for Australian Clinical Labs Limited (ACL)
Operating Margin as of November 2026 TTM: 8.04%
According to Australian Clinical Labs Limited's latest financial reports, its current operating margin (TTM) is 8.04%. At the end of 2025 the company had an operating margin of 36.54%.
Operating Margin history for Australian Clinical Labs Limited from 2017 to 2026
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2026 (TTM) | 8.04% | -78.00% |
| 2025 | 36.54% | 342.91% |
| 2024 | 8.25% | 1.85% |
| 2023 | 8.10% | -70.07% |
| 2022 | 27.06% | 41.53% |
| 2021 | 19.12% | 499.37% |
| 2020 | 3.19% | -287.65% |
| 2019 | -1.70% | 8.28% |
| 2018 | -1.57% | -74.05% |
| 2017 | -6.05% | 0.00% |
Operating Margin for similar companies or competitors
| Company | Operating Margin | Operating Margin Difference | Country |
|---|---|---|---|
| 17.98% | -97.76% |
US
|
|
| 20.38% | -97.47% |
US
|
|
| 43.02% | -94.65% |
CN
|
|
| 32.03% | -96.02% |
US
|
|
| 22.23% | -97.24% |
US
|
What is a company's Operating Margin?
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.
Questions about Australian Clinical Labs Limited's operating margin
What is Australian Clinical Labs Limited's operating margin?
Australian Clinical Labs Limited's operating margin is 8.04%, as of Nov 2026.
What was Australian Clinical Labs Limited's operating margin in 2025?
In 2025, Australian Clinical Labs Limited's operating margin was 36.54%, compared with 8.25% in 2024.
How has Australian Clinical Labs Limited's operating margin changed since 2020?
From 2020 to 2025, Australian Clinical Labs Limited's operating margin was highest in 2025 (36.54%) and lowest in 2020 (3.19%).
How does Australian Clinical Labs Limited's operating margin compare with similar companies?
Australian Clinical Labs Limited's operating margin (8.04%) is lower than that of all 5 similar companies listed above. The highest among them is WuXi AppTec Co., Ltd., with 43.02%.